Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Preclinical and phase I data presented on antimicrobial pleuromutilin BC-3781

April 22, 2010

Characterization of filibuvir resistance in HCV patients when coadministered with PEG-INF/RBV

April 22, 2010

Gilead discloses clinical data on HCV NS3 protease inhibitor GS-9256

April 22, 2010

SCH-900776 sensitizes cancer cells to hydroxyurea and gemcitabine

April 21, 2010

LCL-161 well tolerated in ongoing first-in-human study

April 21, 2010

Decline of mGlu5 receptor binding as a marker of early Alzheimer's disease

April 21, 2010

ONO-8539 for overactive bladder well tolerated in healthy adults

April 21, 2010

Quinacrine does not extend survival in sporadic Creutzfeldt-Jakob disease

April 21, 2010

Data on vipadenant warrant further development in moderate- to late-stage PD patients

April 21, 2010

MTD of EMD-534085 established in phase I trial in advanced solid tumors and lymphoma

April 20, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...